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Characterisation of bone regeneration in 3D
printed ductile PCL/PEG/hydroxyapatite scaffolds
with high ceramic microparticle concentrations†
Chuanliang Cao,a Pengren Huang,b Aruna Prasopthum, ‡c Andrew J. Parsons,d
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3D printed bioactive glass or bioceramic particle reinforced composite scaffolds for bone tissue engineer-
ing currently suffer from low particle concentration (<50 wt%) hence low osteoconductivity. Meanwhile,
composites with very high inorganic particle concentrations are very brittle. Scaffolds combining high
particle content and ductility are urgently required for bone tissue engineering. Herein, 3D printed PCL/
hydroxyapatite (HA) scaffolds with high ceramic concentration (up to 90 wt%) are made ductile (>100%
breaking strain) by adding poly(ethylene glycol) which is biocompatible and FDA approved. The scaffolds
require no post-printing washing to remove hazardous components. More exposure of HA microparticles
on strut surfaces is enabled by incorporating higher HA concentrations. Compared to scaffolds with
72 wt% HA, scaffolds with higher HA content (90 wt%) enhance matrix formation but not new bone
volume after 12 weeks implantation in rat calvarial defects. Histological analyses demonstrate that bone
regeneration within the 3D printed scaffolds is via intramembranous ossification and starts in the central
region of pores. Fibrous tissue that resembles non-union tissue within bone fractures is formed within
pores that do not have new bone. The amount of blood vessels is similar between scaffolds with mainly
fibrous tissue and those with more bone tissue, suggesting vascularization is not a deciding factor for
determining the type of tissues regenerated within the pores of 3D printed scaffolds. Multinucleated
immune cells are commonly present in all scaffolds surrounding the struts, suggesting a role of managing
inflammation in bone regeneration within 3D printed scaffolds.
1. Introduction
3D printing is a promising manufacturing tool for fabricating
scaffolds for bone tissue engineering.1–4 It offers the ability to
precisely control geometry5,6 and to fabricate stratified struc-
tures to mimic the heterogeneity of bone.7 Various materials
including bioceramics,8,9 bioactive glasses,10 and bio-
degradable polymers11 have been used in 3D printing to
produce degradable bone tissue engineering scaffolds. These
materials have a good track record of safety, hence, from a
regulatory point of view, it is relatively easier to translate 3D
printed scaffolds made of them into the clinic. Whilst ceramic
and bioactive glass scaffolds offer relatively high modulus,
strength and osteoconductivity,12 their brittleness is a signifi-
cant concern for clinical applications.13 Bioceramics and bio-
active glasses are intrinsically brittle. They are very sensitive to
the presence of small cracks commonly present in porous
scaffolds, and can fail catastrophically when subjected to
in vivo forces. The ductility of bone scaffolds is critical for their
mechanical reliability. However, this mechanical property has
received less attention compared to modulus and strength. On
the other hand, although polymers such as biodegradable
polyesters are relatively ductile, they are usually hydrophobic
and have poor osteoconductivity and mechanical properties
inferior to cortical bone.14,15
To overcome limitations associated with single materials,
polymer/inorganic composites that mimic, to some extent,
bone (which consists of mainly partially carbonated hydroxy-
apatite and type I collagen fibrils) have been used in 3D print-
ing to combine the ductility of polymers and the osteoconduc-
tivity of the inorganic components.1,11,16,17 A balance between
mechanical properties and osteoconductivity needs to be
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struck for these composites. Modulus and strength initially
increase with the concentration of the inorganic component,
subsequently start to plateau before becoming detrimental to
the mechanical properties at very high concentrations.18
Addition of glass or ceramic microparticles into polymers can
even lower strength and increase brittleness of composites at
very low particle concentrations. For example, in a study in
which the mechanical properties of β-tricalcium phosphate/
PCL composites were tested, modulus of the composites
increased with higher concentrations of the calcium phos-
phate particles up to 60 wt%. However, the yield strengths of
all the composites (20 wt% to 60 wt%) were lower than pure
PCL.19 These studies have demonstrated that although high
concentrations of glass/ceramic particles can increase
modulus, they can also make the composites more brittle with
low strength. As a consequence, the inorganic component is
typically kept at relatively low concentration (<50 wt%).20 On
the other hand, higher concentration of the inorganic com-
ponent is desirable to increase osteoconductivity.21 Low con-
centration of the inorganic component in the composites
leads to less exposure of them on the surface, which compro-
mises their osteoconductivity as most of them are embedded
in the polymer matrix hence not in contact with cells. The
osteoconductive properties of bioactive glasses with certain
compositions and some calcium phosphates have long been
documented. Some studies even showed osteoinductive pro-
perties of these materials, although conflicting data on this
exist in the literature.22 The formation of carbonate hydroxy-
apatite on the material surfaces as well as released ions due to
dissolution have been demonstrated to be key for their good
osteogenic properties.23 It is reasonable to postulate that if the
glass or ceramic particles are not present on the strut surface
of 3D printed scaffolds, their osteoconductive/osteoinductive
properties will be compromised. Only few efforts have been
made to make composites with high-concentration inorganic
component more flexible in which 3D printed scaffolds with
high-concentration hydroxyapatite (HA) micro particles (up to
90 wt%) were made elastic and ductile by adding a surfactant
(2-butoxyethanol) and a plasticizer (Dibutyl phthalate).24
However, the inclusion of these additives may have impli-
cations in safety and regulation.25
Bone regenerates either via intramembranous ossification
or by endochondral ossification.26 Intramembranous ossifica-
tion, which is responsible for the formation of most flat
bones, involves the differentiation of mesenchymal cells to
osteoblasts, the formation of ossification centres and initial
synthesis of collagen fibrils followed by polarized secretion of
bone matrix.27 In endochondral ossification, which is respon-
sible for the formation of long bones, cartilage forms first
before being replaced by bone.28 Bone regeneration via endo-
chondral ossification has been considered to be advantageous
for biomaterial scaffolds supplemented with stem/progenitor
cells due to the requirement of initial vascularization that is
critical for cell survival.29–31 It will be useful to characterise the
route of bone formation for the analysis of in vivo bone regen-
eration within 3D printed scaffolds.
Herein, 3D printed PCL/PEG/HA composites with high con-
centrations (up to 90 wt%) of HA particles were rendered
ductile by adding poly(ethylene glycol) (PEG). PEG is an FDA-
approved biomaterial that has shown good
biocompatibility.32,33 The optimal molecular weight and con-
centration of PEG added to the 3D printing ink formulation
were identified for achieving ductility. The mechanical pro-
perties of individual struts and scaffolds with different HA
concentrations were measured. Bone formation within the 3D
printed scaffolds were tested in vivo using a rat calvarial
model. These 3D printed scaffolds are potentially applicable to
clinical applications that require ductile and surgically trim-
mable materials.
2. Materials and methods
2.1 Strut and scaffold fabrication
Polycaprolactone (PCL, Mn = 80 000 g mol
−1), poly(ethylene
glycol) (PEG, Mn = 400, 3350, 20 000 Da) and hydroxyapatite
microparticles (product number 289396) were all purchased
from Sigma-Aldrich (UK). The size distribution of the hydroxy-
apatite microparticles is shown in Fig. S1.† Various formu-
lations of PCL/PEG/HA were made by first dissolving PEG in di-
chloromethane (DCM), then adding HA microparticles and
vortexed until homogeneous, lastly adding PCL and agitating
the mixture on a roller overnight. All struts and scaffolds were
made using a pneumatic extrusion-based 3D printer
(RegenHU, Switzerland) at room temperature in air using a
conical needle with a nozzle diameter of 260 μm. The individ-
ual struts were extruded at a pressure of 4 bar and then col-
lected in a tray 10–15 cm below the needle. Scaffolds were fab-
ricated by extrusion-based 3D printing using a pressure of 4–6
bar and a printing speed of 12–20 mm s−1. After the printing
process, all the individual struts and scaffolds were dried in
air for 24 hours at room temperature to eliminate the residual
solvent (DCM).
2.2 Mechanical property testing
Single strut tensile testing was performed using a sensitive
tensile test facility (LEX810, Diastron Ltd, UK) (Fig. S2†). Struts
were fixed individually onto the plastic tabs with a 10 mm
gauge length setup. Prior to testing, the diameters of the fibres
were measured using an optical microscope. And the samples
were stretched to 400% strain at a crosshead speed of 0.04 mm
s−1 at room temperature in air. Compression testing of
scaffolds was performed using a universal texture analyser
(TA-HD Plus, Stable Microsystems, USA). The scaffolds (24
layers), with dimensions of 8 (width) × 8 (width) × 4.3 (height)
mm3, were compressed in the height direction with a speed of
0.03 mm s−1 to the strain of 60%. The compressive modulus
was calculated from the initial linear range of the stress–strain
curves (strain range 1% to 5%). At least three specimens were
tested for each sample group. Tensile testing was carried out
using a universal testing machine with a 10 kN load cell
(CMT6104, Mets Industrial Systems Co., Ltd) at a rate of
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0.17 mm s−1. Scaffolds (6 layers) used in the tensile testing
had dimensions of 20 × 10 × 1 mm3.
2.3 Scanning electron microscope (SEM)
SEM images were obtained by using a JSM-6490 scanning elec-
tron microscope (JEOL, UK). Scaffold samples were mounted
on stubs and sputter coated with gold/palladium before
imaging. For cell-laden scaffolds, the specimens were fixed in
2.5% (v/v) glutaraldehyde/PBS and stained with 1%(v/v)
osmium tetroxide prior to dehydration.
2.4 In vitro cell culture
The human mesenchymal stem cells (hMSCs) (TCS Cellworks,
UK) were immortalised according to a previous protocol.34 The
cells were expanded in Dulbecco’s modified Eagle’s (DMEM)
medium with 10% (v/v) FBS, 1% (v/v) L-glutamine, 1% (v/v) 1%
(v/v) antibiotic/antimycotic (AB/AM) solution and 1% (v/v) non-
essential amino acids. The scaffolds were sterilised in 70%
(v/v) ethanol for 1 hour, washed with PBS and incubated in
DMEM medium containing 10% (v/v) FBS before cell seeding.
1 × 106 cells were seeded into each 3D printed PCL/HA scaffold
(1 × 1 × 0.5 cm3). The osteogenic differentiation medium
(αMEM with 10% (v/v) FBS, 1% (v/v) L-glutamine and 1% (v/v)
antibiotic/antimycotic solution, 10 mM β-glycerophosphate,
100 nM dexamethasone) was then added after initial attach-
ment of cells to the scaffolds. The hMSC-seeded scaffolds were
cultured for 21 days during which the osteogenic differen-
tiation medium was changed twice a week.
hMSC-seeded scaffolds that were cultured in the osteogenic
differentiation medium were harvested at different days (day 1,
day 7, day 14, and day 21). They were individually washed with
ice-cold PBS, homogenised in a lysis buffer containing the
Halt™ protease inhibitor cocktail (Thermo Fisher Scientific,
UK), and freeze-thawed for three cycles to promote cell lysis.
The clear supernatants were then used to measure the quantity
of DNA and osteocalcin (a late marker of osteogenesis) using
PicoGreen™ and an enzyme-linked immunosorbent assay kit
(Thermo Fisher Scientific, UK), respectively. All samples and
standards were performed in triplicate. The cell-free scaffolds
were used as negative controls.
2.5 In vivo testing of scaffolds in rat calvarial defects
The rat calvarial defect model was established on six 8-week
old male Spraguee Dawley rats provided by Jiangxi University
of Traditional Chinese Medicine (Nanchang, China). Each rat
weighted approximately 200 g. All animal procedures were per-
formed in accordance with the guidelines for care and use of
laboratory animals of Nanchang University and approved by
the Animal Ethics Committee of the Second Affiliated Hospital
of Nanchang University. Briefly, the rats were anesthetized
with 10% chloral hydrate (4 ml kg−1), and the skin of the surgi-
cal site was shaved. The rats were fixed on the operating table
and iodophor was used to disinfect the skin of the surgical
site. A longitudinal incision about 3 cm long was made along
the sagittal line of the skull to expose the skull. Two calvarial
defects with a diameter of 5 mm were drilled on both sides of
parietal bone with a surgical trephine (Fig. S3†). Rat calvarial
defects with 5 mm diameter have been widely used as a bone
regeneration model though it may not be considered as criti-
cal-sized defects.35,36 5 mm defect size allowed the introduc-
tion of two defects per rat and the avoidance of the sagittal
suture spanning the defect. The operation site was continu-
ously rinsed with saline to reduce heat during drilling. Two
different scaffold groups (72% HA and 90% HA) were sterilized
by ethylene oxide before being implanted into the defect sites.
Six samples were used for each group of scaffolds and two
different scaffolds were implanted in a rat. Incisions were then
sutured. After waking up, the rats were moved into a clean
animal room. All the experimental animals were in good con-
dition and no wound infection was identified. The scaffolds
used for implantation were 5 mm in diameter and were
punched out from printed scaffolds (mean pore size – 380 μm,
strut diameter – 280 μm, porosity – 67% (pores between struts)
and 7 layers).
2.6 Gross morphology and micro-CT
After 12 weeks, the animals were sacrificed under general
anesthesia, and the specimens were retrieved with some sur-
rounding host bone and fixed with 10% formalin. Gross mor-
phology images were taken using an optical microscope
(A005+, Shenzhen SuperEye Technology, China). The fixed
specimens were scanned with custom made Micro-CT (Xidian
University, Shaanxi, China) with a tube voltage of 78 kV and a
tube current of 100 μA. After scanning, a software for isosur-
face rendering (3D Med 5.0, Chinese Academy of Sciences) was
used for 3D reconstruction to evaluate the degree of
mineralization.
2.7 Histological analysis
Following Micro-CT analysis, the scaffolds were decalcified in
0.5 M EDTA decalcifying solution for 30 days with frequent
changing of the solution every 2–3 days. The specimens were
then embedded in paraffin blocks, and transversal slices with
4 µm thickness were cut from the middle of each defect using
a microtome. The slices were then washed in xylene to remove
paraffin followed by rehydration in ethanol series and water
before being stained with hematoxylin and eosin (H&E). For
immunohistochemistry, the slices were firstly dewaxed in the
same way as those used for H&E staining. They were then incu-
bated in 3% hydrogen peroxide solution followed by 3%
bovine serum albumin to block endogenous peroxidase and
non-specific binding, respectively, before being incubated with
primary anti-Collagen II or anti-osteocalcin (OCN) antibodies.
The slices were then washed and incubated in secondary anti-
bodies tagged with horseradish peroxidase followed by being
stained in 3,3′-diaminobenzidine chromogenic solution to
produce a brown colour where collagen II or OCN was present.
All reagents used for histology were from Wuhan Servicebio
Technology, China. All images were obtained by an optical
microscope (NIKON Eclipse Ci, Japan). Eosin-stained area was
measured by using the colour deconvolution function in
ImageJ with the same threshold range for all images (National
Biomaterials Science Paper



























































































Institutes of Health, USA). The quantification of collagen II
and OCN area was carried out using the IHC plugin in ImageJ
as described before.37
2.8 Statistical analysis
All data were presented as mean ± standard deviation (SD).
Statistical analysis was performed on GraphPad Prism 5 soft-
ware (Minitab Inc., State College, PA, USA) using one-way ana-
lysis of variance (ANOVA) to test for significance. Post hoc
Tukey’s multiple-comparison test was used to determine the
individual differences among the groups. Unpaired T test was
used when there were only two groups compared.
3. Results
3.1 Effects of PEG concentration and molecular weight on
the mechanical properties of struts and scaffolds
Fig. 1 shows two 3D printed structures with a high HA : PCL
mass ratio (9 : 1). PEG400 was added to the PCL/HA blend to
render ductility. The printed sheet (4 layers) was foldable
whilst counterparts without PEG fractured easily after slight
bending (Fig. 1a, Fig. S4†). A movie of the folding and unfold-
ing process can be found in Movie S1.† Thicker structures
were also printable with satisfactory fidelity (Fig. 1b).
To identify the optimal PEG concentration and molecular
weight that were used in the structures shown in Fig. 1 for
improving ductility, PEGs with different molecular weights
(400, 3350, 20 000 Da) were added to PCL/HA at different con-
centrations. Individual struts that were made of these
materials were measured for their tensile properties. The
tensile properties were measured both before and after
soaking in water (24 hours) as PEG is hydrophilic and leaches
out in aqueous environments. The struts that were soaked in
water were dried in air for at least 24 hours before tensile
testing. Representative stress–strain curves are shown in
Fig. S5.†
Fig. 2 shows the breaking strains of PCL/PEG/HA composite
struts with different concentrations and different molecular
weights of PEG. For PEG20000 and PEG3350, when the mass
ratio of PEG : PCL was below 10 : 10, the struts demonstrated a
brittle characteristic, similar to PCL/HA without PEG, before
and after immersion. When the mass ratio of PEG : PCL
reached 10 : 10, the struts were still relatively brittle. However,
the ductility increased dramatically after immersion. The
breaking strains increased from 6.2% and 12.1% to 47.9% and
190.5% for the PEG(3350) and PEG(20k) containing struts,
Fig. 1 3D printed sheet and scaffold consisting of PEG400/PCL/HA composite struts (mass ratio PEG : PCL : HA = 7 : 10 : 90). (a) Rolling, folding and
unfolding of a printed sheet (4 layers). (b) Gross views and SEM images of a printed thick scaffold.
Fig. 2 Tensile breaking strain of PCL/PEG/HA struts. The PCL : HA mass
ratio was fixed at 1 : 9. Struts were tested in air. Immersion means that
struts were soaked in water for 24 hours and then dried in air before
testing. Data represent mean ± SD, n = 5. Lines are used only for guiding
the eyes.
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respectively. For struts with PEG(400), the ductility of struts
increased at lower PEG : PCL ratios, indicating better plasticiz-
ing effect of PEG400. The ductility of struts with PEG400 was
better before immersion in contrast to those with higher mole-
cular weight PEGs. When the mass ratio of PEG400 : PCL
reached 7 : 10, the breaking strain was 260.9% and reduced to
121.2% after immersion but still ductile.
The tensile moduli and strengths of the struts before and
after immersion in water are shown in Fig. 3. For PEG(20k)
and PEG(3350), PEG showed only marginal effect on the
modulus and strength when the PEG : PCL ratio was 5 : 10 and
lower before immersion. The elastic modulus and strength
decreased when the ratio was 7 : 10 and higher. For struts with
PEG(400) the moduli were lower than those with PEG(20k) and
PEG(3350) at all three ratios (3 : 10, 5 : 10 and 7 : 10). In con-
trast to the two high molecular weight PEGs, the moduli of
struts with PEG(400) increased after immersion. Immersion in
water showed relatively less effect to strength compared to
modulus. It is worth noting that immersion showed no signifi-
cant effect for the PCL/HA struts without PEG. The mass of
struts dropped rapidly after immersion in water for
30 minutes, then kept almost constantly up to 28 days
(Fig. S6†). Mass reduction showed that the mass losses were
almost equal to the amounts of PEG that were added to the
struts, suggesting most of the PEG leached out after immer-
sion in water for 30 minutes (Fig. S6†).
3.2. Effect of HA concentration on the mechanical properties
of struts and scaffolds
PEG(400) was demonstrated to be a better plasticizer to endow
ductility to the composite struts as less PEG(400) was required
to increase breaking strain (Fig. 2). PEG(400) was therefore
selected as the plasticizer with a fixed mass ratio of PEG
(400) : PCL at 7 : 10. The mechanical properties of struts with
different HA contents (72 wt%, 84 wt% and 90 wt%, 94 wt%)
were then tested. These HA concentrations represent the per-
centages of HA in the total mass of HA and PCL as PEG
leaches out during immersion.
Fig. 4 shows the tensile mechanical properties of struts
with various HA contents. Before immersion in water, the
elastic modulus, ultimate tensile strength and breaking strain
decreased with the increasing HA concentration. The trend
was largely the same for immersed struts that had PEG
leached out. It is worth noting that the struts with the highest
HA concentration (94 wt%) were ductile before immersion,
albeit with a lower breaking strain of 92.4%. However, the
ductility disappeared for these struts after 24 hours of immer-
sion in water.
After measuring the individual struts, the tensile mechani-
cal properties of 3D printed scaffolds made of PEG(400)/PCL/
HA were then tested. Fig. 5 shows the tensile properties of 3D
printed scaffolds consisting of the ductile struts. As the
scaffolds were porous, the mechanical properties of the
scaffolds were much lower than the individual struts. The
breaking strains of the scaffolds were also significantly lower
than the individual struts, though still larger than 100%,
meaning ductility of the 3D printed scaffolds.
Fig. 6 shows the results of the compression testing of the
scaffolds with various HA concentrations. The compressive
properties of the scaffolds demonstrated similar trends to the
tensile properties of struts. As the HA concentration increased,
both compressive yield strength and modulus decreased. After
Fig. 3 Modulus and strength measured using single strut tensile testing. (a and b) PEG(20k)/PCL/HA, (c and d) PEG(3350)/PCL/HA, (e and f) PEG
(400)/PCL/HA. The mass ratio of PCL to HA was fixed at 1 : 9. Data represent mean ± SD, n = 5.
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immersion, the compressive yield strength and modulus
increased, especially for the 90% HA scaffolds which increased
from 0.35 MPa and 2.64 MPa to 0.82 MPa and 18.31 MPa for
yield strength and modulus, respectively. The increase in
modulus of the scaffolds after immersion was consistent with
what was observed for the struts with PEG(400).
3.3 Morphology of PCL/PEG/HA struts with different HA
concentrations
Fig. 7 shows the SEM images of PCL/PEG(400)/HA scaffolds
with various HA concentrations (72 wt%, 84 wt%, 90 wt%, and
94 wt%). The surface of the 72% HA scaffold was relatively
smoother than the others with some HA micro particles visible
on the strut surface. There seemed to be more presence of HA
particles in the 72% HA scaffolds after immersion in water. As
the HA concentration increased, there was significantly more
exposure of the HA particles. The levels of HA exposure for the
84%, 90% and 94% HA scaffolds were similar. There were
visible pores between the HA particles in the struts when the
HA concentration was higher than 72%. Besides the pores
between the HA particles, microscopic pores were visible
within the polymer matrix for the 84% HA and 90% HA
scaffolds (Fig. 7 insets). These pores might be due to the phase
separation between PCL and PEG.38 However, the 94% HA
scaffold showed no sign of pores within the polymer matrix,
possibly due to the very small amount of PCL and PEG in the
composite.
3.4 In vitro osteogenic differentiation and In vivo bone
regeneration in rat calvarial defects
We first characterized in vitro osteogenic differentiation of
human mesenchymal stem cells within three different 3D
Fig. 4 Breaking strain, Young’s modulus and Ultimate tensile strength of the PCL/PEG400/HA struts (mass ratio PEG(400) : PCL = 7 : 10) with
different HA concentrations. Data represent mean ± SD, n = 5. * indicates p < 0.05, ** indicates p < 0.01 and *** indicates p < 0.001.
Fig. 5 Tensile properties of 3D printed scaffolds (6 layers) consisting of ductile struts. Data represent mean ± SD, n = 4. * indicates p < 0.05, ** indi-
cates p < 0.01 and *** indicates p < 0.001.
Fig. 6 Compression modulus and yield strength of PCL/PEG(400)/HA
scaffolds with different HA concentrations. Data represent mean ± SD, n
= 3. Lines are used only for guiding the eyes.
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Fig. 7 SEM images of PCL/PEG(400)/HA scaffolds with varied HA concentrations. Insets show the high-magnification images of strut surfaces. The
scale bars in insets are 10 μm.
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printed scaffolds (Pure PCL, 72 wt% and 90 wt%). The actual
hydroxyapatite contents in these scaffolds quantified by thermo-
gravimetric analysis were similar to the theoretical values
(Fig. S7†). Osteocalcin was selected as an osteogenic differen-
tiation marker. Cell proliferation and secretion of osteocalcin
are shown in Fig. 8. hMSCs proliferated with similar rates
between the three different types of scaffolds. The amount of
osteocalcin (normalized to DNA content) was significantly
higher for the 90% HA scaffolds. Soaking scaffolds in simulated
body fluid appeared to cause more apatite formation on the
90% HA scaffolds (Fig. S8†). The enhanced osteogenic differen-
tiation for the 90% HA scaffolds might be attributed to the
increased strut surface mineralization. Cell attachment and
morphology within the scaffolds during in vitro cell cultivation
were also monitored using SEM (Fig. S9†). Cell attachment and
spreading were visible in all scaffolds.
We then characterized bone regeneration using a rat calvar-
ial model. Scaffolds with two HA concentrations (72 wt% and
90 wt%) were implanted in rat calvarial defects. PEG within
the scaffolds was not removed before implantation. The two
HA concentrations were selected based on the distinct differ-
ence in the presence of HA on the strut surfaces. In addition,
the 94% HA scaffolds were mechanically weak during manual
handling.
Fig. 9 shows the gross morphology, micro-CT images and
H&E staining of the retrieved scaffolds after 12 weeks in vivo.
The scaffolds largely maintained their shape after implan-
tation for 12 weeks. Given the slow degradation rate of both
PCL and HA, it was not expected to see significant degradation
during the in vivo testing period. According to the gross mor-
phology, more scaffolds of the 72% HA group showed translu-
cent fibrous tissue within them. The regenerated tissues
within the 90% HA scaffolds appeared to be denser than those
in the 72% HA scaffolds. The micro-CT images showed that
the pores of the scaffolds were not completely mineralized and
varied levels of mineralization were apparent. Comparing the
gross morphology to the micro-CT images, it was clear that not
all the optically opaque tissues have been mineralized.
Comparing the H&E staining to micro-CT images, areas within
the scaffolds that were stained brightly pink by Eosin, similar
to the host bone at both ends of the scaffolds, were new bone.
Locations that were stained less intensively pink appeared to
be fibrous tissue. Whilst most new tissue appeared to be
within the pores some scaffolds (sample 4, 10) showed new
bone on the scaffold surface as demonstrated by the microCT
images and the H&E staining.
Quantification of the Eosin-stained area showed that there
was significantly more matrix in the 90% HA scaffolds
(Fig. 10). However, when mineral volume within the scaffold
pores was quantified using the microCT images, it was not
statistically different between the two types of scaffolds
(Fig. 10). It was not possible to differentiate new bone from the
scaffolds during the quantification of the microCT images,
hence scaffolds and new bone were combined as mineral
volume.
To investigate the tissue formed with the pores of the
scaffolds in more detail, higher magnification images were
taken from the H&E stained samples (Fig. 11 and Fig. S10†).
Fibrous tissue surrounded the struts with aligned collagen
fibres conforming with the contour of the struts. It was con-
sistently observed that more cells infiltrated into the struts of
the 90% scaffolds compared to those of the 72% scaffolds
(Fig. S10†). This was likely caused by the fact that the struts
with 90% HA were more porous than those in the 72% HA
scaffolds (Fig. 7). Multinucleated cells have been commonly
found surrounding the struts (Fig. 11, Fig. S10†). Blood vessels
are commonly seen within the fibrous tissue with erythrocytes
stained brightly pink within them. The amount of blood
Fig. 8 DNA content and osteocalcin secretion of in vitro cultured immortalised hMSCs within three different scaffolds. Data represent mean ± SD,
n = 3. * indicates p < 0.05.
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vessels was comparable between the two types of scaffolds
when vessel areas were quantified in the H&E staining images
(Fig. 11c). 70% HA scaffolds which mostly had fibrous tissues
within the pores also contained a good amount of blood
vessels (Fig. 11b).
As some tissue within the 90% HA scaffolds that were opti-
cally dense but not mineralized resembled cartilage, in con-
junction with the aim to identify the route of bone formation,
expression of collagen II (chondrogenic markers) was analysed
using immunohistochemistry (Fig. 12). In general, the level of
collagen II presence within the scaffold was low. In addition,
collagen II was not evenly distributed in the tissue within the
pores (Fig. 12, Fig. S11†). Some areas showed relatively more
intensive staining of collagen II, which might be an indication
Fig. 9 Image of scaffolds after 12-week implantation in rat calvarial defects. Row 1&2 – Gross morphology of retrieved scaffolds. Row 3&4 –
MicroCT images of the scaffolds. Row 5&6 – H&E staining (pink staining) of transverse cross-sectional slices of the scaffolds. Six samples were
tested for each scaffold composition. Scale bars are 2 mm.
Fig. 10 Mineral volume (including both new bone and scaffold) and quantified matrix area (Eosin stained) within scaffolds. * denotes p < 0.05, Data
represent mean ± SD, n = 6.
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of difference in cellular differentiation status. OCN was also
stained as an osteogenic differentiation marker. Although
quantification of OCN appeared to be higher in the 90% HA
scaffolds, but there was no statistical difference between the
compared groups (Fig. 12).
For scaffolds that had new bone formation, immuno-
staining of collagen II and H&E staining revealed that new
bone regenerated in the pores was formed via intramembra-
nous ossification (Fig. 13). Fig. 13a and 13b are H&E and col-
lagen II staining of the same 72% HA scaffold. The central
Fig. 11 High magnification images of H&E staining of (a) 90% HA and (b) 72% HA scaffold. The presence of blood vessels, multinucleated cells and
osteocytes within regenerated bone are visible. Red arrow – blood vessel; black arrow – multinucleated cells; Green arrow – osteocyte; NB – new
bone. (c) Quantified blood vessel area from H&E images. Blood vessel areas were manually selected in individual images and quantified by using
ImageJ. Date represent mean ± SD, n = 18.
Fig. 12 Quantified immunostaining of collagen II and OCN of the 72% HA and 90% HA scaffolds. The images used for quantification are included in
Fig. S12 and 13.†
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region of the eosin stained new bone showed absence of col-
lagen II (Fig. 13d and e). The presence of collagen II was most
intensive in areas that immediately surrounded the new bone
(Fig. 13d–f ). The morphology of the new bone tissue rep-
resents the process of bone formation via intramembranous
ossification in which mesenchymal cells condense and differ-
entiate to osteoblasts that secret osteoid (Fig. 13d inset).27
4 Discussion
This study aimed to test: (1) the effectiveness of PEG on
endowing ductility to PCL/HA composites with high HA con-
centrations; (2) how the level of HA exposure on strut surface
affects bone regeneration; and (3) the route of bone regener-
ation within the pores (pores between struts) of the 3D printed
scaffolds in vivo. PEG was chosen because of its biocompatibil-
ity and demonstrated plasticizing effect on polymers.39,40 In
this study, PCL/PEG/HA composites with high HA contents
were endowed with ductility by adding PEG alone, which
means there is no need to wash the scaffolds after printing to
remove hazardous additives. In addition, our previous data
showed that residual DCM in 3D printed scaffolds can evapor-
ate to safe levels in air.41
PEG with lower molecular weight (400 Da) was shown to be
a better plasticizer as the ductility of struts (increased breaking
strain) was achieved with a lower concentration. One study
reported the effect of the molecular weight of PEG on the
Fig. 13 H&E staining and immunostaining of collagen II (brown). (a) H&E staining and (b) Immunostaining of collagen II of the same 72% HA
scaffold showing tissue formed within the pores. (c–e) are high-magnification images of the areas within the dashed boxes. Inset in (d) is a sche-
matic of intramembranous ossification. (f ) Immunostaining of collagen II of a 90% HA scaffold. Blue arrow−cells morphologically resemble osteo-
blasts; Green arrow – osteocyte; Yellow arrow – fibrous tissue; Red arrow – blood vessel; NB – new bone; HB – host bone.
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toughness of PCL/PEG/Starch blends, which showed an
optimal molecular weight of 3400 Da (when compared against
400, 8000 and 100 000 Da) for maximum toughness and break-
ing strain.42 However, this three-component blend is different
from the ones in our study, and the toughness depended on
the interaction between the three components and the inter-
action between PEG(400) and PCL was shielded by starch.
Instead of a gradual increase of ductility with increasing
PEG content as reported before,40 our results showed a dra-
matic increase in ductility after reaching a threshold of
PEG : PCL ratio which is molecular weight dependent (7 : 10
for PEG(400), 10 : 10 for PEG(3350) and PEG(20k)). For struts
with PEG(3350) and PEG(20k) which are solid at room temp-
erature, ductility was obtained only after the struts were
immersed in water. The increase in ductility after immersion
may be attributed to the removal of brittle PEG-rich domains
which might be formed as a result of the phase separation
between PEG and PCL.38 It was found that the ductility was
largely maintained or improved even after most PEG leached
out after immersion (Fig. 2, Fig. S5†). Interestingly when a rela-
tively small amount of PEG was added (PEG : PCL < 5 : 10), the
increase in failure strain was marginal. This may be due to
that the free volume created by the plasticizer (PEG) was still
present after the leaching out of PEG.43 Indeed, ductility dis-
appeared after annealing the struts which removed the free
volume created by the addition of PEG (Fig. S14†).
In general, the elastic modulus and strength of the struts
and scaffolds decreased with increasing HA content (Fig. 4–6).
This is likely due to the decreasing amount of PCL matrix
which binds the particles together and consequently the
reduced ability in transferring load from the polymer matrix to
the HA particles.44 It was clear from the SEM images that
higher concentration of HA particles in the struts resulted in
more apparent exposure of them on the strut surface, particu-
larly when the concentration was higher than 70 wt% (Fig. 7).
The trade-off between mechanical properties and the amount
of exposed HA particles on the strut surface led us to study the
effect of HA concentration on the formation of bone in vivo to
identify if high-concentration HA is beneficial for bone for-
mation. The in vivo data demonstrated that more HA exposure
on strut surface (90% HA scaffolds) enhanced matrix for-
mation within the pores, but not mineral volume compared to
the 72% HA scaffolds. Previous studies have reported ben-
eficial effect of higher ceramic concentration on osteogenesis.
However, the reported ceramic concentrations were lower than
the ones studied here.45 The long-term effect of high HA con-
centration on bone regeneration requires further investigation.
It is worth noting that the strut topography was different
between the two types of scaffolds. There is ample evidence
that topography affects the differentiation of mesenchymal
stem cells in vitro.46 However, effect of topography on bone
regeneration in vivo is less clear47 though improved osseointe-
gration associated with implant surface roughness has been
reported before.48 Although the compressive mechanical pro-
perties of the scaffolds are inferior to cortical bones, they are
within the lower end of the mechanical property range of can-
cellous bone.49,50 It is envisaged that the 3D printed ductile
scaffolds could be used in non-load bearing applications for
bone regeneration. For them to be used in load-bearing appli-
cations, innovative ways of mechanically reinforcing these
high-inorganic-concentration struts will need to be explored in
the future.
Histological analyses (H&E staining,
Immunohistochemistry of collagen II) were carried out to
study the tissues formed within the pores in more detail and
to exam the route of bone formation within 3D printed
scaffolds, which is under-investigated. Moreover, a recent
study reported endochondral ossification induced by aligned
pores within collagen sponges which have some level of resem-
blance to the regular pore arrangement in 3D printed
scaffolds.51 Therefore, it was intriguing to investigate how
bone is formed within the 3D printed scaffolds. According to
the gross morphologies, the tissues formed in the 72% HA
scaffolds appeared to be more translucent and less dense com-
pared to those within the 90% HA scaffolds. The fibrous tissue
found in the scaffolds resembles what has been observed in
non-union bone fractures in humans.52 Some visually opaque
white tissues that were not mineralized according to microCT
images resembled cartilage. Therefore, immunostaining of col-
lagen II was carried out to study if those tissues were cartilagi-
nous. Neither large areas that showed intensively stained col-
lagen II nor cells morphologically resemble chondrocytes were
found. Instead, as demonstrated by H&E staining and immu-
nohistochemistry of collagen II, bone within the pores was
regenerated via intramembranous ossification. During intra-
membranous ossification a condensation of mesenchymal
cells develops, within which osteoblasts differentiate and
deposit mainly collagen type I with some type II and III,27,53
which explains the presence of some collagen II surrounding
the new bone. It was noticed that collagen II was not evenly
distributed in the fibrous tissues with some areas having rela-
tively higher levels (Fig. 13, Fig. S11†), which indicated that
the mesenchymal cell population within the fibrous tissue
may consists of sub-populations that were functionally
different. Partial dissolution of hydroxyapatite followed by the
formation of carbonated hydroxyapatite has been reported to
trigger a mineralization of the ECM leading to bone for-
mation,54 which has been considered to contribute to the
bonding between hydroxyapatite and host bone. However,
bone formation within the pores appeared to start in the
central region rather than initiating from the strut surface
(Fig. 13). Some pores with bone formation have shown proxi-
mity between the new bone and the strut surface whilst others
have shown a relatively thicker fibrous layer between the new
bone and the strut surface (Fig. 13). New bone within these
pores might continue growing until it meets the strut surface.
Comparing scaffolds with varied levels of bone formation,
the amount of blood vessels did not appear to be significantly
different among them (Fig. 11). This suggests that the level of
vascularization, while important for progenitor cell recruit-
ment and transportation of oxygen and nutrients, is not a
responsible factor for the varying levels of bone regeneration
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within the different scaffolds. This is similar to what has been
reported in literature in which no significant difference was
evident in the vessel count between atrophic/hypertrophic
non-unions and normal unions.55 Multinucleated cells were
commonly observed surrounding the struts. It is likely that
these cells are multinucleated giant cells given their close
association with the struts, which is a hallmark of foreign
body reaction (FBR). It was not surprising to find the presence
of these cells as FBR is common in biomaterial implants and
PCL and HA degrade slowly.56 On the other hand, osteoclasts
are multinucleated cells derived from the fusion of mono-
nuclear precursors belonging to the monocyte/macrophage
lineage.57 Bone remodeling relies on the actions of both osteo-
clasts and osteoblasts. The presence of these multinucleated
cells may accelerate the degradation of HA in vivo.58 Moreover,
immune response is an intimate part of bone fracture
healing.59 Inflammatory response elicited by bone injury is
beneficial to healing when it is acute and regulated. However,
if this process is dysregulated and chronic, inflammation can
be detrimental to healing.60 Mesenchymal stem/progenitor
cells have been found in non-union tissues despite little bone
regeneration being present in the fracture sites.61 Senescence
of stem/progenitor cells presents one of the main mechanisms
of the loss of the regenerative potential leading to healing
impairment. Mesenchymal stromal cells isolated from atrophic
non-union tissues have shown senescence and a reduced
capacity to differentiate into mature and functional osteo-
blasts.62 The varied level of bone formation within the
scaffolds may hence be linked to the level of inflammation
sensed by the stromal cells in the tissue within the pores.
Where new bone was formed within the scaffold pores, a layer
of fibrous tissue between struts and new bone was often
observed, which may be an indication of the inhibitory effect
of prolonged inflammation on bone formation. However, the
functionality of these stromal cells, particularly their osteo-
genic potential and their interactions with immune cells, need
more detailed analysis in the future.
5 Conclusion
3D printed scaffolds that are osteoconductive and have
sufficient mechanical properties for bone tissue engineering
are urgently needed. The route of bone formation within these
scaffolds also requires detailed analysis. PEG has been demon-
strated to be an effective plasticizer to make high-HA-concen-
tration (up to 90 wt% HA) scaffolds ductile. The failure strain
of individual struts increased significantly from 6.2% to
260.9% by adding PEG400. These 3D printed PCL/PEG/HA
scaffolds did not require further post-printing washing to
remove hazardous components before implantation. More HA
exposure caused by high HA concentration was demonstrated
to enhance matrix formation though at a cost of lower
modulus and strength of the scaffolds. However, the mechani-
cal properties were still within the range of cancellous bone
and sufficient for non-load bearing applications. Moreover, we
have demonstrated that new bone within the pores of 3D
printed scaffolds was formed via intramembranous ossifica-
tion and started from the central region of pores. The amount
of blood vessels formed within the pores did not seem to be
significantly different between scaffolds with varied bone for-
mation. The data has also suggested a role of immune
response associated with the presence of synthetic biomater-
ials on bone regeneration, which warrants further
investigation.
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